|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：T009202 |
| 產(chǎn)品名稱：Tauroursodeoxycholic-2,2,3,4,4-d5 Acid |
| 產(chǎn)品CAS：1207294-25-4 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
T009202 |
| 名稱: |
Tauroursodeoxycholic-2,2,3,4,4-d5 Acid |
| 別名: |
2-[[(3α,5β,7β)-3,7-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic-d5 Acid; 3α,7β-Dihydroxy-5β-cholan-24-oic Acid N-(2-Sulfoethyl)amide-d5; Ursodeoxycholyltaurine-d5; |
| CAS號(hào): |
1207294-25-4 |
| 參考CAS號(hào): |
類似: 14605-22-2 |
| 分子式: |
C??H??D?NO?S |
| 外觀: |
白色至白色固體 |
| 熔點(diǎn): |
154-158°C |
| 分子量: |
504.73 |
| 儲(chǔ)存: |
-20°C Freezer, Under Inert Atmosphere |
| 溶解度: |
Methanol |
| 類別: |
Standards; Steroids; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
